v3 Template
S

STRM.BIO

Biotechnology ~260 employees
Founded
--
Employees (Est.)
~260
13 leaders known
Total Funding
$8.0M
Funding Rounds
1
Last Funding
2026-01-07

About STRM.BIO

STRM.BIO is a biotechnology company focused on developing a non-viral, cell-derived delivery platform for safe, targeted, and scalable in vivo delivery of genetic medicines. Initially targeting rare hematological diseases like Fanconi anemia and in vivo CAR-T therapies, their mission is to overcome limitations of viral and synthetic delivery systems and bring new therapeutic approaches to gene editing, RNA therapeutics, and immune cell engineering.

Products & Services

Megakaryocyte-derived Vesicle (MV) Platform:A non-viral delivery platform designed for precise and efficient delivery of complex genetic cargos to the bone marrow, with potential for repeat dosing and applications across gene editing, RNA therapeutics, and immune cell engineering.

Specialties

Non-viral gene delivery In vivo cell and gene therapy Rare hematological diseases CAR-T therapies Gene editing RNA therapeutics Immune cell engineering

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series Seed 2
T: -
FT: Series Seed 2 		A: 8000000
MR: -
FA: $8 million
FAN: 8000000 		D: 2026-01-07
FD: 2026-01-07 		4 investors
Series Seed 2 Latest
2026-01-07
$8.0M
4 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

M

Michael Luther

CEO

LinkedIn (Pro only)
R

Robert Hughes

Chief Financial Officer

LinkedIn (Pro only)
L

Laura Goldberg

VP of Research and Development

LinkedIn (Pro only)
M

Matt Simmons

Senior Director, Platform Development

F

Fei Shen

Managing Director at Boehringer Ingelheim Venture Fund

T

Tim Xiao

Partner and founding team member

View 10 more team members with Pro

Unlock Full Team Directory

Recent News

STRM.BIO Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Website
strm.bio
Industries
Biotechnology
Company Size
~260 employees (est.)

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro